Group 1 (TXA group) will receive 2000mg (20ml) of Tranexamic Acid (TXA) intravenously 5 minutes before incision.
Sponsors
Dr Benjamin Cass
Phase 4
Intravenous tranexamic acid ("TXA") and its effect on operating conditions, blood loss, post-operative pain and complications in patients undergoing total shoulder replacement.
CompletedACTRN12616000723482
Start: 2016-10-17End: 2017-08-25Target: 150Updated: 2020-01-13
Intravenous tranexamic acid ("TXA") and its effect on post-operative pain and stiffness in patients undergoing total shoulder arthroscopy and rotator cuff repair.
CompletedACTRN12617001074381
Start: 2017-11-09End: 2020-03-09Target: 100Updated: 2021-12-06